Viewing StudyNCT00136292



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00136292
Status: COMPLETED
Last Update Posted: 2020-03-11
First Post: 2005-08-25

Brief Title: Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
Sponsor: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA

Organization Data

Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Class: INDUSTRY
Study ID: 3009-028
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators